Crossmark

Chemotherapy reprograms miRNA expression profiles in apoptotic extracellular vesicles from medulloblastoma cells, regulating pro- and anti-proliferative effects on recipient drug-naïve cells

Crossref DOI link: https://doi.org/10.1186/s12964-025-02241-9

Published Online: 2025-06-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ignacio, Rosa Mistica C.

Forgham, Helen

Ma, Zerong

Jensen, Anya

Sharbeen, George

Ruan, Juanfang

Ziegler, David S.

Tsoli, Maria

Phillips, Phoebe A.

Mayoh, Chelsea

Kavallaris, Maria

McCarroll, Joshua
Funding

Funding for this research was provided by:

National Health and Medical Research Council (App2002707, 2017898, App2002707, App2002707)

Cancer Institute NSW (2021/CBG0003)

National Health and Medical Research Council,Australia (APP2016464)

Ross Trust (N/A)

Cancer Australia (APP1184840)
License Information

Text and Data Mining valid from 2025-06-10

Version of Record valid from 2025-06-10
More Information

Article History

Received: 18 December 2024

Accepted: 9 May 2025

First Online: 10 June 2025

Declarations

:

: The animal experiments were approved by the University of New South Wales Animal Care and Ethics Committee according to the Animal Research Act, 1985, under the ethics number ACEC 19/11B (New South Wales, Australia) and the Australian Code for the Care and Use of Animals for Scientific Purposes (2013).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below